Quality key factors
Factor
Value
Sales Growth (5y)
0.20%
EBIT Growth (5y)
-194.22%
EBIT to Interest (avg)
-8.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.71
Sales to Capital Employed (avg)
0.00
Tax Ratio
0.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
0.08
EV to EBITDA
0.10
EV to Capital Employed
-0.21
EV to Sales
-1.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-134.31%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Movement
12What is working for the Company
NET SALES(HY)
At PLN 0.02 MM has Grown at 340%
NET PROFIT(HY)
Higher at PLN -3.5 MM
RAW MATERIAL COST(Y)
Fallen by -63.93% (YoY
-3What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -11.76 %
Here's what is working for Genomtec SA
Net Sales
At PLN 0.02 MM has Grown at 340%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (PLN MM)
Net Profit
Higher at PLN -3.5 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (PLN MM)
Raw Material Cost
Fallen by -63.93% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Genomtec SA
Debt-Equity Ratio
Highest at -11.76 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






